Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age
Simple Summary
Calabretta, R.; Staber, P.B.; Kornauth, C.; Lu, X.; Binder, P.; Pichler, V.; Mitterhauser, M.; Haug, A.; Li, X.; Hacker, M. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology 2021, 10, 1206. https://doi.org/10.3390/biology10111206
Calabretta R, Staber PB, Kornauth C, Lu X, Binder P, Pichler V, Mitterhauser M, Haug A, Li X, Hacker M. Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology. 2021; 10(11):1206. https://doi.org/10.3390/biology10111206
Chicago/Turabian StyleCalabretta, Raffaella, Philipp B. Staber, Christoph Kornauth, Xia Lu, Patrick Binder, Verena Pichler, Markus Mitterhauser, Alexander Haug, Xiang Li, and Marcus Hacker. 2021. "Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age" Biology 10, no. 11: 1206. https://doi.org/10.3390/biology10111206